Follow the AFLAC INC share price and the full management transaction log of the company, a listed issuer based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Operating in the Banks sector, AFLAC INC has recorded 438 reports. Market capitalisation: €58.4bn. The latest transaction was filed on 31 August 2026 (Cession). Among the most active insiders: Japan Post Holdings Co., Ltd.. Every trade is free.
Analysts rate AFLAC INC Hold (neutral), based on 15 analysts. Average price target: US$118.53.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
25 of 438 declarations
Aflac Incorporated (NYSE: AFL) is a leading U.S.-listed supplemental insurance company headquartered in Columbus, Georgia, United States. Founded in 1955 by John Amos and his brothers Paul and Bill, the company started with a clear mission: to provide financial protection when a medical event occurs. That original purpose still defines the business today. Aflac is best known for paying cash benefits directly to policyholders for eligible claims, helping them manage out-of-pocket costs that are not covered by primary health insurance. The company operates through two core reporting segments: Aflac Japan and Aflac U.S. In Japan, Aflac is a major player in cancer and medical insurance and is described by the company as the leading provider of cancer and medical insurance policies in force. In the United States, Aflac focuses on supplemental health and life products sold primarily through the workplace and other distribution channels. Its U.S. portfolio includes accident, cancer, hospital indemnity, critical illness, life, and dental, vision and hearing coverage. These products are designed to address deductibles, copays, non-medical costs, and other expenses that traditional major medical insurance may not fully cover. Aflac’s competitive positioning is anchored in three strengths: brand recognition, specialization, and distribution reach. The Aflac Duck has become one of the most recognizable insurance advertising icons in the U.S. and Japan, helping the company sustain high brand awareness over time. Distribution is broad and diversified, combining commissioned sales, brokers, distribution partners, and digital enhancements. The company is authorized to conduct insurance business in all 50 U.S. states, the District of Columbia, several U.S. territories, and Japan, giving it a wide commercial footprint. From an investor perspective, Aflac is often viewed as a defensive insurance name with a relatively straightforward value proposition and a strong recurring premium base. It has also continued to evolve its product set and distribution capabilities, including investments in digital sales methods and broader platform enhancements. Recent company disclosures show ongoing operating momentum: in first-quarter 2026, Aflac reported results and said adjusted earnings per diluted share increased 5.4%. In 2025, the company disclosed a cybersecurity incident affecting its U.S. business, a reminder that operational and reputational risks remain relevant for the investment case. Overall, Aflac combines a long operating history, a distinctive niche in supplemental insurance, a strong market presence in both the United States and Japan, and a well-established brand. For investors focused on the insurance sector, it represents a mature, cash-generative franchise with a differentiated product mix and a reputation built over decades.